Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 228
Filtrar
1.
Actas urol. esp ; 47(6): 341-350, jul.- ago. 2023. tab
Artigo em Espanhol | IBECS | ID: ibc-223181

RESUMO

Introducción y objetivo La implantación de prótesis deZ pene (PP) es una alternativa eficaz para la disfunción eréctil. Aunque inicialmente la cirugía de PP se realizaba en régimen hospitalario, existe una tendencia creciente a realizar el implante de PP en un modelo de cirugía mayor ambulatoria (CMA). El objetivo de este estudio es realizar una revisión sistemática de la literatura para identificar la evidencia disponible sobre la implantación de PP en el marco de la CMA en comparación con el procedimiento realizado en régimen hospitalario. Material y métodos Se realizó una búsqueda en las bases de datos electrónicas PubMed, EMBASE, Cochrane Library y MEDES y en los suplementos no indexados de los congresos científicos para identificar artículos relacionados con la implantación quirúrgica de PP en CMA hasta febrero de 2021. Los términos de búsqueda incluyeron prótesis de pene, disfunción eréctil, cirugía ambulatoria, atención ambulatoria y cirugía. Resultados Entre las 171 publicaciones obtenidas (51 en PubMed, 73 en EMBASE, 3 en Cochrane, 2 mediante MEDES y 42 mediante búsqueda manual), se seleccionaron finalmente 5 estudios. No hubo diferencias significativas entre la CMA y el régimen hospitalario en términos del tipo de dispositivo, el abordaje quirúrgico o la ubicación del reservorio. Las tasas de complicaciones observadas en ambos grupos fueron similares. La implantación de PP en régimen de CMA supuso un menor coste que la cirugía en régimen hospitalario y se asoció con tasas aceptables de satisfacción de los pacientes y un adecuado control del dolor. Conclusiones Los estudios demostraron que la implantación de PP en régimen de CMA puede lograr resultados similares en términos de seguridad y satisfacción a la implantación de PP en el régimen hospitalario, pudiendo también reducir los costes y mejorar la eficiencia. Esta investigación podría ayudar a los responsables de la toma de decisiones a extender la cirugía de PP al régimen ambulatorio (AU)


Introduction and objective Penile prosthesis (PP) implantation is an effective option for erectile dysfunction. Although initially PP surgery was carried out in an inpatient setting, there is a growing trend to implant PP in a major ambulatory surgery (MAS). This study aimed to perform a systematic review of the literature to identify available evidence of the implantation of PP under MAS setting and go carry out a comparison between MAS and inpatient procedures. Material and methods PubMed, EMBASE, Cochrane Library and MEDES electronic databases and non-indexed supplements for scientific congresses were searched to identify articles related to the surgical implantation of PP in MAS up to February 2021. Key search terms included penile prosthesis, erectile dysfunction, ambulatory surgery, ambulatory care, and surgery. Results Among 171 publications retrieved (51 PubMed, 73 EMBASE, 3 Cochrane, 2 using MEDES and 42 manual searching), 5 studies were finally selected. There were no significant differences between MAS or inpatient setting in terms of the type of device, surgical approach, or location of reservoir. Complication rates observed in both groups were similar. Implantation of PP in MAS was less expensive than inpatient surgery and was associated with acceptable patient satisfaction rates and adequate pain control. Conclusions Studies demonstrated that outpatient PP surgery can achieve similar outcomes in terms of safety and satisfaction to implantation of PP in the inpatient setting, while it could reduce costs and improve the efficiency. This research could provide support decision makers to extend PP surgery into the ambulatory setting (AU)


Assuntos
Humanos , Masculino , Implante Peniano/métodos , Procedimentos Cirúrgicos Ambulatórios , Disfunção Erétil/cirurgia , Prótese de Pênis , Resultado do Tratamento
2.
Actas Urol Esp (Engl Ed) ; 47(6): 341-350, 2023.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-36319559

RESUMO

INTRODUCTION AND OBJECTIVE: Penile prosthesis (PP) implantation is an effective option for erectile dysfunction. Although initially PP surgery was carried out in an inpatient setting, there is a growing trend to implant PP as a major ambulatory surgery (MAS). This study aimed to perform a systematic review of the literature to identify available evidence of the implantation of PP under MAS setting and go carry out a comparison between MAS and inpatient procedures. MATERIAL AND METHODS: PubMed, EMBASE, Cochrane Library and MEDES electronic databases and non-indexed supplements for scientific congresses were searched to identify articles related to the surgical implantation of PP in MAS up to February 2021. Key search terms included penile prosthesis, erectile dysfunction, ambulatory surgery, ambulatory care, and surgery. RESULTS: Among 171 publications retrieved (51 PubMed, 73 EMBASE, 3 Cochrane, 2 using MEDES and 42 manual searching), 5 studies were finally selected. There were no significant differences between MAS or inpatient setting in terms of the type of device, surgical approach, or location of reservoir. Complication rates observed in both groups were similar. Implantation of PP in MAS was less expensive than inpatient surgery and was associated with acceptable patient satisfaction rates and adequate pain control. CONCLUSIONS: Studies demonstrated that outpatient PP surgery can achieve similar outcomes in terms of safety and satisfaction to implantation of PP in the inpatient setting, while it could reduce costs and improve the efficiency. This research could support decision makers to extend PP surgery into the ambulatory setting.


Assuntos
Disfunção Erétil , Implante Peniano , Prótese de Pênis , Humanos , Masculino , Procedimentos Cirúrgicos Ambulatórios , Disfunção Erétil/cirurgia , Implante Peniano/métodos , Prótese de Pênis/efeitos adversos , Pênis/cirurgia
3.
BMC Gastroenterol ; 22(1): 326, 2022 Jul 02.
Artigo em Inglês | MEDLINE | ID: mdl-35780112

RESUMO

BACKGROUND: Transarterial radioembolization (TARE) with yttrium-90 microspheres is a clinically effective therapy for hepatocellular carcinoma (HCC) treatment. This study aimed to perform a systematic review of the available economic evaluations of TARE for the treatment of HCC. METHODS: The Preferred Reported Items for Systematic reviews and Meta-Analyses guidelines was followed by applying a search strategy across six databases. All studies identified as economic evaluations with TARE for HCC treatment in English or Spanish language were considered. Costs were adjusted using the 2020 US dollars based on purchasing-power-parity ($US PPP). RESULTS: Among 423 records screened, 20 studies (6 cost-analyses, 3 budget-impact-analyses, 2 cost-effectiveness-analyses, 8 cost-utility-analyses, and 1 cost-minimization analysis) met the pre-defined criteria for inclusion. Thirteen studies were published from the European perspective, six from the United States, and one from the Canadian perspectives. The assessed populations included early- (n = 4), and intermediate-advanced-stages patients (n = 15). Included studies were evaluated from a payer perspective (n = 20) and included both payer and social perspective (n = 2). TARE was compared with transarterial chemoembolization (TACE) in nine studies or sorafenib (n = 11). The life-years gained (LYG) differed by comparator: TARE versus TACE (range: 1.3 to 3.1), and TARE versus sorafenib (range: 1.1 to 2.53). Of the 20 studies, TARE was associated with lower treatment costs in ten studies. The cost of TARE treatment varied widely according to Barcelona Clinic Liver Cancer (BCLC) staging system and ranged from 1311 $US PPP/month (BCLC-A) to 71,890 $US PPP/5-years time horizon (BCLC-C). The incremental cost-utility ratio for TARE versus TACE resulted in a 17,397 $US PPP/Quality-adjusted-Life-Years (QALY), and for TARE versus sorafenib ranged from dominant (more effectiveness and lower cost) to 3363 $US PPP/QALY. CONCLUSIONS: Economic evaluations of TARE for HCC treatment are heterogeneous. Overall, TARE is a cost-effective short- and long-term therapy for the treatment of intermediate-advanced HCC.


Assuntos
Carcinoma Hepatocelular , Quimioembolização Terapêutica , Neoplasias Hepáticas , Canadá , Carcinoma Hepatocelular/radioterapia , Análise Custo-Benefício , Feminino , Humanos , Neoplasias Hepáticas/radioterapia , Microesferas , Gravidez , Sorafenibe/uso terapêutico
4.
Fisioterapia (Madr., Ed. impr.) ; 44(2): 80-87, mar.-abr. 2022. ilus, tab
Artigo em Espanhol | IBECS | ID: ibc-203747

RESUMO

Antecedentes y objetivo: Determinar si existe asociación entre dependencia funcional, capacidad funcional e intensidad del dolor en personas mayores con artrosis de cadera. Materiales y métodos: Estudio transversal-analítico con reclutamiento consecutivo de 85 individuos. Se evaluó dependencia funcional (índice de Barthel), capacidad funcional (WOMAC) y dolor (escala numérica del dolor). Se determinaron diferencias en capacidad funcional y dolor, según la condición de dependencia funcional. Además, se analizó la correlación entre estas variables. Todos los análisis consideraron un nivel de significación de p<0,05. Resultados: Ochenta y cinco participantes (72,26±5,69 años de edad; 54,12% mujeres) fueron incluidos en el estudio. Los promedios para el índice de Barthel, WOMAC e intensidad del dolor fueron 94,00±9,35; 44,49±17,08 y 6,09±3,12 respectivamente. Del total de participantes 46 fueron clasificados como independientes. El análisis demostró que los participantes clasificados como dependientes presentaron un mayor puntaje en WOMAC-total (p=0,001), WOMAC-dolor (p=0,037), WOMAC-función (p<0,001) y dolor (p=0,010), con tamaños de efecto entre medio y grande. No se encontró diferencias en WOMAC-rigidez (p=0,184). Se encontró una correlación inversa, moderada y significativa entre los puntajes de WOMAC-total (p<0,001), WOMAC-dolor (p=0,007), WOMAC-función (p<0,001) e intensidad del dolor (p=0,002) con el puntaje de dependencia funcional de Barthel, pero no con WOMAC-rigidez (p=0,141). Conclusiones: Los individuos con artrosis de cadera avanzada dependientes funcionalmente tienen una capacidad funcional menor y una intensidad del dolor mayor que los clasificados como independientes. Esta información provee un insumo valioso para clínicos y para la planificación de estrategias de salud.


Background and aim: To determine the association between functional dependence, functional capacity, and pain intensity in older adults with hip osteoarthritis. Methods: Cross-sectional study with a consecutive sampling of 85 participants. Functional dependence (Barthel Index), functional capacity (WOMAC questionnaire), and pain (Numerical Rating Scale) were measured. Differences between functional capacity and pain, depending on functional dependence status were determined. Moreover, correlation analyses were performed between these outcomes. All analyses considered a significance level of p<.05. Results: 85 participants (72.26±5.69 years old; 54.12% women) were included. Mean values for Barthel Index, WOMAC, and pain intensity were 94.00±9.35; 44.49±17.08 and 6.09±3.12, respectively. Of the total participants, 46 were classified as independent. The analysis showed that participants classified as dependent exhibited a higher score in WOMAC-total (p=.001), WOMAC-pain (p=.037), WOMAC-function (p<.001), and pain intensity (p=.01), with medium to high effect sizes. No differences were seen in WOMAC-stiffness (p=.184). An inversed, moderate correlation between the Barthel Index and WOMAC-total (p<.001), WOMAC-pain (p=.007), WOMAC-function (p<.001) and pain intensity (p=.002) were seen, but not in WOMAC-stiffness (p = .141). Conclusion: Functionally dependent older adults with advanced hip osteoarthritis have lower functional capacity and higher pain intensity than those classified as functionally independent. This information provides a valuable insight for clinicians to plan future health strategies.


Assuntos
Humanos , Masculino , Feminino , Idoso , Aptidão Física , Idoso Fragilizado , Osteoartrite do Quadril , Dor , Desempenho Físico Funcional , Estudos Transversais , Métodos de Análise Laboratorial e de Campo
5.
J Reprod Immunol ; 146: 103339, 2021 08.
Artigo em Inglês | MEDLINE | ID: mdl-34087539

RESUMO

In pigs, the number of PMN in uterus lumen increases within few hours after natural or artificial AI resulting in early PMN-derived innate immune reactions. Sperm-NETs formation was recently reported to occur in various mammalian species. Aim of this study was to investigate direct interactions of boar spermatozoa with swine PMN, the release of sperm-mediated NETs, and to assess NET-derived effects on sperm functionality. Sperm-triggered NETs were visualized by SEM- and immunofluorescence analyses. Sperm-mediated NETosis was confirmed by presence of extruded DNA with global histones and NE. Largest sizes of sperm-mediated aggNETs were detected after 5 h thereby resulting in effective massive sperm entrapment. The number of aggNETs increased from 3 h onwards. Kinetic studies of swine sperm-mediated NETosis showed to be a time-dependent cellular process. In addition, number of NETs-entrapped spermatozoa increased at 3 h of exposure whilst few free spermatozoa were detected after 3 h. Anchored NETs also increased from 3 h onwards. The cytotoxicity of NETs was confirmed by diminution of the total motility and the progressive motility. Spermatozoa membrane integrity and function loss exposed to NETs was confirmed from 3 h. Experiments revealed NETs-derived damaging effects on swine spermatozoa in membrane integrity, motility and functionality. We hypothesize that swine sperm-triggered aggNETs might play a critical role in reduced fertility potential in swine reproductive technique. Thus, aggNETs formation needs to be considered in future studies about uterine environment as well as advance of sperm in the porcine female reproductive tract.


Assuntos
Armadilhas Extracelulares/imunologia , Fertilidade/imunologia , Inseminação Artificial/veterinária , Espermatozoides/imunologia , Criação de Animais Domésticos , Animais , Células Cultivadas , Técnicas de Cocultura , Feminino , Masculino , Cultura Primária de Células , Morte Celular Regulada/imunologia , Motilidade dos Espermatozoides , Suínos
6.
Clin Nutr ; 39(5): 1447-1453, 2020 05.
Artigo em Inglês | MEDLINE | ID: mdl-31256806

RESUMO

BACKGROUND AND AIMS: Disease-related malnutrition is a prevalent condition that can be associated with multimorbidity. The purposes of this study were to assess the prevalence of disease-related malnutrition in a cohort of chronic patients with complex needs (CPCN) admitted to two University hospitals, and to evaluate the impact of malnutrition in their hospitalization outcomes. METHODS: All CPCN admitted on a previously agreed day in non-critical services of two University hospitals in Catalonia were included. Nutritional risk was evaluated with Mini-Nutritional Assessment Tool and Nutritional Risk Screening 2002. Hospitalization outcome data were evaluated, including length of the hospital stay, mortality during admission and placement when discharged. After five months, a new evaluation was performed to assess mortality and readmissions. RESULTS: A total of 101 patients were included, 83% of which were at nutritional risk when screened with NRS-2002; when using MNA, 86% of them were found to be either at nutritional risk or malnourished. Malnourished patients had a greater need for home care/intermediate care hospital at discharge (41.8% vs 22.9%, p < 0.01), and a higher mortality rate during admission (16.7% vs 1.6%, p < 0.01). Mortality at 5 months was also higher in the malnourished group (30.5% vs 9.8%, p < 0.01). Factors associated with malnutrition were BMI and gender (malnutrition was more prevalent in women). In our cohort, malnutrition was the sole independent predictor of mortality at 5 months. CONCLUSIONS: The prevalence of both malnutrition and risk of malnutrition is very high in hospital-admitted CPCN, and has a profound impact on placement at discharge and mortality. This high prevalence is not explained by the multimorbidity pattern. Other factors need to be evaluated in this group of high-need, high-cost patients.


Assuntos
Pacientes Internados , Desnutrição/diagnóstico , Idoso , Idoso de 80 Anos ou mais , Estudos de Coortes , Estudos Transversais , Feminino , Hospitalização , Humanos , Masculino , Pessoa de Meia-Idade , Estado Nutricional , Fatores de Risco
7.
Vet Immunol Immunopathol ; 201: 77-87, 2018 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-29914687

RESUMO

Fatty and hydroxycarboxylic acids are one of the main intermediates of energy metabolism in ruminants and critical in the milk production of cattle. High production demands on a dairy farm can induce nutritional imbalances and metabolism disorders, which have been widely associated with the onset of sterile inflammatory processes and increased susceptibility to infections. The literature suggests that short-chain fatty acids (SCFA), long-chain fatty acids (LCFA) and hydroxycarboxylic acids are relevant modulators of the host innate inflammatory response. For instance, increased SCFA and lactate levels are associated with subacute ruminal acidosis (SARA) and the activation of pro-inflammatory processes mediated by diverse leukocyte and vascular endothelial cells. As such, free LCFA and the ketone body ß-hydroxybutyrate are significantly increased in the plasma 1-2 weeks postpartum, coinciding with the time period in which cows are more susceptible to acquiring infectious diseases that the host innate immune system should actively oppose. Today, many of these pro-inflammatory responses can be related to the activation of specific G protein-coupled receptors, including GPR41/FFA3 and GPR43/FFA2 for SCFA; GPR40/FFA1 and GPR120/FFA4 for LCFA, GPR109A/HCA2 for ketone body ß-hydroxybutyrate, and GPR81/HCA1 for lactate, all expressed in different bovine tissues. The activation of these receptors modulates the release of intracellular granules [e.g., metalloproteinase-9 (MMP-9) and lactoferrin], radical oxygen species (ROS) production, chemotaxis, and the production of relevant pro-inflammatory mediators. The article aimed to review the role of natural ligands and receptors and the resulting impact on the host innate immune reaction of cattle and, further, to address the most recent evidence supporting a potential connection to metabolic disorders.


Assuntos
Acidose/veterinária , Ácidos Graxos não Esterificados/imunologia , Imunidade Inata , Doenças Metabólicas/veterinária , Receptores Acoplados a Proteínas G/imunologia , Acidose/metabolismo , Animais , Bovinos/imunologia , Bovinos/metabolismo , Metabolismo Energético , Ácidos Graxos Voláteis/imunologia , Feminino , Inflamação , Lactatos/metabolismo , Doenças Metabólicas/imunologia , Espécies Reativas de Oxigênio/metabolismo
8.
Vet Immunol Immunopathol ; 191: 68-73, 2017 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-28895869

RESUMO

Cytoplasmic pH homeostasis is required for an appropriate response in polymorphonuclear neutrophils (PMNs). In these cells, chemotaxis and reactive oxygen species (ROS) production are reduced by the use of Na+/H+ exchanger (NHE-1) inhibitors, but these results are mainly obtained using amiloride, a non-selective NHE-1 inhibitor. In bovine PMNs, the role of NHE-1 in functional responses has not been confirmed yet. The aim of this study was to determine the role of NHE-1 using amiloride and zoniporide in pH regulation, ROS production, matrix metalloproteinase 9 (MMP-9) release and calcium flux in bovine PMNs induced by the platelet activation factor (PAF), additionally we evaluated the presence of NHE-1 and NHE-2 mRNA Our data show the presence only of NHE-1 but not NHE-2 in bovine PMNs. Amiloride or zoniporide inhibited the intracellular alkalization induced by PAF without affecting calcium flux. Amiloride diminished ROS production and MMP-9 release, while zoniporide enhanced ROS production without change the MMP-9 release induced by PAF. Our work led us to conclude that changes in intracellular pH induced by PAF are regulated by NHE-1 in bovine neutrophils, but the effects of amiloride on ROS production and MMP-9 release induced by PAF are not NHE-1 dependent.


Assuntos
Amilorida/farmacologia , Metaloproteinase 9 da Matriz/metabolismo , Neutrófilos/efeitos dos fármacos , Fator de Ativação de Plaquetas/antagonistas & inibidores , Explosão Respiratória/efeitos dos fármacos , Trocador 1 de Sódio-Hidrogênio/antagonistas & inibidores , Animais , Cálcio/metabolismo , Bovinos , Feminino , Guanidinas/farmacologia , Neutrófilos/enzimologia , Neutrófilos/metabolismo , Fator de Ativação de Plaquetas/farmacologia , Reação em Cadeia da Polimerase/veterinária , Pirazóis/farmacologia , Espécies Reativas de Oxigênio/metabolismo , Trocador 1 de Sódio-Hidrogênio/metabolismo
9.
J Phys Condens Matter ; 29(12): 125701, 2017 Mar 29.
Artigo em Inglês | MEDLINE | ID: mdl-28059777

RESUMO

We consider a one-dimensional photonic crystal made by an infinite set of nonlinear nematic films immersed in a linear dielectric medium. The thickness of each equidistant film is negligible and its refraction index depends continuously on the electric field intensity, giving rise to all the involved nonlinear terms, which joints from a starting linear index for negligible amplitudes to a final saturation index for extremely large field intensities. We show that the nonlinear exact solutions of this system form an intensity-dependent band structure which we calculate and analyze. Next, we ponder a finite version of this system; that is, we take a finite array of linear dielectric stacks of the same size separated by the same nonlinear extremely thin nematic slabs and find the reflection coefficients for this arrangement and obtain the dependence on the wave number and intensity of the incident wave. As a final step we analyze the stability of the analytical solutions of the nonlinear crystal by following the evolution of an additive amplitude to the analytical nonlinear solution we have found here. We discuss our results and state our conclusions.

10.
Vet Immunol Immunopathol ; 176: 18-27, 2016 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-27288853

RESUMO

Increased short-chain fatty acid (SCFA) production is associated with subacute ruminal acidosis (SARA) and activation of inflammatory processes. In humans and rodents, SCFAs modulate inflammatory responses in the gut via free fatty acid receptor 2 (FFA2). In bovines, butyric acid is one of the most potent FFA2 agonists. Its expression in bovine neutrophils has recently been demonstrated, suggesting a role in innate immune response in cattle. This study aimed to evaluate if butyric acid modulates oxidative and non-oxidative functions or if it can potentiate other inflammatory mediators in bovine neutrophils. Our results showed that butyric acid can activate bovine neutrophils, inducing calcium (Ca(2+)) influx and mitogen-activated protein kinase (MAPK) phosphorylation, two second messengers involved in FFA2 activation. Ca(2+) influx induced by butyric acid was dependent on the extracellular and intracellular Ca(2+) source and phospholipase C (PLC) activation. Butyric acid alone had no significant effect on reactive oxygen species (ROS) production and chemotaxis; however, a priming effect on platelet-activating factor (PAF), a potent inflammatory mediator, was observed. Butyric acid increased CD63 expression and induced the release of neutrophil granule markers matrix metalloproteinase-9 (MMP-9) and lactoferrin. Finally, we observed that butyric acid induced neutrophil extracellular trap (NET) formation without affecting cellular viability. These findings suggest that butyric acid, a component of the ruminal fermentative process, can modulate the innate immune response of ruminants.


Assuntos
Ácido Butírico/farmacologia , Bovinos/imunologia , Neutrófilos/efeitos dos fármacos , Fator de Ativação de Plaquetas/farmacologia , Animais , Cálcio/metabolismo , Quimiotaxia de Leucócito , MAP Quinases Reguladas por Sinal Extracelular/metabolismo , Armadilhas Extracelulares/efeitos dos fármacos , Ácidos Graxos não Esterificados/metabolismo , Neutrófilos/imunologia , Neutrófilos/metabolismo , Espécies Reativas de Oxigênio/metabolismo , Proteínas Quinases p38 Ativadas por Mitógeno/metabolismo
11.
BMC Neurol ; 16: 77, 2016 May 23.
Artigo em Inglês | MEDLINE | ID: mdl-27215274

RESUMO

BACKGROUND: Andrographis paniculata (A. paniculata), a medicinal plant, has shown anti-inflammatory, neuroprotective and antifibrotic effects in animal models as well as clinical efficacy in different studies, including an anti-fatigue effect in autoimmune diseases such as rheumatoid arthritis. In multiple sclerosis (MS), fatigue is rated as one of the most common and disabling symptoms. In the present trial, we investigated the effect of A. paniculata on relapse rate and fatigue in relapsing-remitting MS (RRMS) patients receiving interferon beta. METHODS: A randomised double-blind placebo-controlled trial assessed the effects of 170 mg of A. paniculata dried extract tablet b.i.d. p.o. on relapse rate and fatigue using the Fatigue Severity Scores (FSS) over 12 months in RRMS patients receiving interferon. The Expanded Disability Status Scale (EDSS) score, inflammatory parameters and radiological findings were also investigated. Twenty-five patients were enrolled, and twenty-two patients were ultimately analysed and randomised to the active or placebo group. RESULTS: Patients treated with A. paniculata showed a significant reduction in their FSS score as compared to the placebo, equivalent to a 44 % reduction at 12 months. No statistically significant differences were observed for relapse rate, EDSS or inflammatory parameters, with a trend in reducing new lesions among the A. paniculata group. One patient in the A. paniculata group presented with a mild and transient skin rash, which was alleviated with anti-histamine treatment for three weeks. CONCLUSION: A. paniculata was well tolerated in patients and no changes in clinical parameters were observed. A. paniculata significantly reduces fatigue in patients with RRMS receiving interferon beta in comparison to placebo and only interferon beta treatment. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02280876 ; Trial registration date: 20.10.2014.


Assuntos
Andrographis , Fadiga/tratamento farmacológico , Esclerose Múltipla Recidivante-Remitente/complicações , Esclerose Múltipla Recidivante-Remitente/tratamento farmacológico , Fitoterapia , Extratos Vegetais/uso terapêutico , Adolescente , Adulto , Animais , Método Duplo-Cego , Fadiga/etiologia , Feminino , Humanos , Interferon beta/uso terapêutico , Masculino , Pessoa de Meia-Idade , Projetos Piloto , Adulto Jovem
12.
J Nutr Health Aging ; 20(4): 370-5, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-26999235

RESUMO

BACKGROUND: Disease-associated malnutrition (DAM) is a health problem involving all sanitary levels, especially hospitalised elderly patients. Different MNA (Mini Nutritional Assessment)-based forms have been validated in different settings, but it remains unclear if they are appropriate to evaluate the nutritional status of geriatric hospitalised patients with diabetes. OBJECTIVE: The aim of this work was to analyse the accuracy of several MNA reduced forms to detect malnutrition in hospitalised elderly diabetic patients. METHODS: A multicentre observational study was carried out in diabetic patients, who were over the age of 65, from 35 Spanish hospitals. Principal component analysis (PCA) selected the minimal components to elaborate the newly-proposed reduced new version of the MNA (r-MNA). Cohen's Kappa index (KI), with its 95% confidence interval (CI), was used to measure the agreement between the different reduced forms (r-MNA, MNA-SF-BMI, MNA-SF-CC, m-MNA) with the original MNA. RESULTS: Five hundred and ninety-one elderly diabetic patients were included in the study. ROC analysis determined the following cut-off points for the newly proposed r MNA: 0-<10 "malnourished", 10-12 "at risk" and >12-15 "well-nourished". The upper cut-off point demonstrated a sensitivity of 87.7%, a specificity of 78.3% and an area under the curve of 0.93. The lower cut-off point showed a sensitivity of 95.9%, a specificity of 78.3% and an area under the curve of 0.95. The best agreement with the original MNA was observed for the MNA-SF-BMI (Κ index 80.7; 95% CI: 77.4-84) and the worst for the r-MNA (Κ index 72; 95% CI: 68.2-75.4). CONCLUSIONS: This study found that MNA-SF-BMI is the most accurate screening tool for determining the nutritional status of hospitalised diabetic elderly patients. This is an easy-to-use, fast screening tool with a low risk of misclassification.


Assuntos
Complicações do Diabetes/diagnóstico , Avaliação Geriátrica/métodos , Desnutrição/complicações , Desnutrição/diagnóstico , Avaliação Nutricional , Estado Nutricional , Idoso , Feminino , Hospitalização , Humanos , Pacientes Internados , Masculino , Análise de Componente Principal , Curva ROC , Risco , Sensibilidade e Especificidade , Espanha
13.
J Vet Pharmacol Ther ; 39(2): 183-90, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-26010096

RESUMO

The aim of this study was to determine the effect of Escherichia coli lipopolysaccharide (LPS)-induced acute phase response (APR) on the pharmaco-kinetics and biotransformation of florfenicol (FFC) in rabbits. Six rabbits (3.0 ± 0.08 kg body weight (bw)) were distributed through a crossover design with 4 weeks of washout period. Pairs of rabbits similar in bw and sex were assigned to experimental groups: Group 1 (LPS) was treated with three intravenous doses of 1 µg/kg bw of E. coli LPS at intervals of 6 h, and Group 2 (control) was treated with an equivalent volume of saline solution (SS) at the same intervals and frequency of Group 1. At 24 h after the first injection of LPS or SS, an intravenous bolus of 20 mg/kg bw of FFC was administered. Blood samples were collected from the auricular vein before drug administration and at different times between 0.05 and 24.0 h after treatment. FFC and florfenicol-amine (FFC-a) were extracted from the plasma, and their concentrations were determined by high-performance liquid chromatography. A noncompartmental pharmacokinetic model was used for data analysis, and data were compared using the paired Student t-test. The mean values of AUC0-∞ in the endotoxaemic rabbits (26.3 ± 2.7 µg·h/mL) were significantly higher (P < 0.05) than values observed in healthy rabbits (17.2 ± 0.97 µg·h/mL). The total mean plasma clearance (CLT ) decreased from 1228 ± 107.5 mL·h/kg in the control group to 806.4 ± 91.4 mL·h/kg in the LPS-treated rabbits. A significant increase (P < 0.05) in the half-life of elimination was observed in the endotoxaemic rabbits (5.59 ± 1.14 h) compared to the values observed in healthy animals (3.44 ± 0.57 h). In conclusion, the administration of repeated doses of 1 µg/kg E. coli LPS induced an APR in rabbits, producing significant modifications in plasma concentrations of FFC leading to increases in the AUC, terminal half-life and mean residence time (MRT), but a significant decrease in CLT of the drug. As a consequence of the APR induced by LPS, there was a reduction in the metabolic conversion of FFC to their metabolite FFC-a in the liver, suggesting that the mediators released during the APR induced significant inhibitory effects on the hepatic drug-metabolizing enzymes.


Assuntos
Antibacterianos/farmacocinética , Escherichia coli , Lipopolissacarídeos/toxicidade , Tianfenicol/análogos & derivados , Reação de Fase Aguda , Animais , Antibacterianos/sangue , Antibacterianos/metabolismo , Área Sob a Curva , Feminino , Meia-Vida , Masculino , Coelhos , Tianfenicol/sangue , Tianfenicol/metabolismo , Tianfenicol/farmacocinética
14.
Hepatogastroenterology ; 62(140): 971-7, 2015 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-26902039

RESUMO

BACKGROUND/AIMS: Mean survival in hepatocellular carcinoma remains low. Many efforts have been done during the last years through screening, diagnosis and treatment to improve the results. The aim of this work is to present the experience of our hospital multidisciplinary group during the first decade of this century. METHODOLOGY: The patients with hepatocellullar carcinoma presented at the multidisciplinary meeting from 1999 to 2009 were prospectively studied. According to the tumor and functional status they were treated through the current available guidelines by transplant, partial hepatectomy, local/regional procedures, systemic or symptomatic treatment. RESULTS: One hundred and forty two patients were studied. Median tumor size was 3 cm. A single tumor was diagnosed in 64.8% of the patients. Eighteen patients had liver resection (6 transplantation and 12 with partial resection), 53 tumors were not treated due to advanced stage or liver dysfunction, and in the remaining patients radiofrequency, ethanol or embolization treatments were used, single or combined. CONCLUSIONS: a multidisciplinary approach of hepatocellular carcinoma in a second level hospital with trained professionals permits a diagnosis in early tumoral and functional stages in the majority of patients, and a variety of possible treatments with adequate survival outcomes.


Assuntos
Técnicas de Ablação , Antineoplásicos/uso terapêutico , Carcinoma Hepatocelular/terapia , Quimioembolização Terapêutica , Hepatectomia , Neoplasias Hepáticas/terapia , Transplante de Fígado , Equipe de Assistência ao Paciente , Idoso , Carcinoma Hepatocelular/etiologia , Carcinoma Hepatocelular/patologia , Ablação por Cateter , Estudos de Coortes , Embolização Terapêutica , Feminino , Hepatite B Crônica/complicações , Hepatite C Crônica/complicações , Humanos , Hepatopatias Alcoólicas/complicações , Neoplasias Hepáticas/etiologia , Neoplasias Hepáticas/patologia , Masculino , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Niacinamida/análogos & derivados , Compostos de Fenilureia , Estudos Prospectivos , Centros de Cuidados de Saúde Secundários , Sorafenibe , Resultado do Tratamento , Carga Tumoral
15.
Rev. psiquiatr. infanto-juv ; 32(1): 59-66, 2015. tab
Artigo em Espanhol | IBECS | ID: ibc-185796

RESUMO

La despersonalización es un fenómeno frecuente pero escasamente estudiado y muy probablemente infradiagnosticado debido, en parte, a las dificultades que los pacientes encuentran para expresar sus experiencias. Estas dificultades son probablemente mayores en los niños lo que hace que sea un trastorno poco estudiado en esta población. A partir del Caso Clínico de un niño de doce años diagnosticado de este trastorno realizamos una revisión de la literatura publicada de la despersonalización en la infancia


Depersonalization is a common phenomenon but poorly studied and probably underdiagnosed, due in part to the difficulties that patients found to express their experiences. These difficulties are probably greater in children and it makes that this disorder is rarely studied in this population. From a Case Report of a twelve year old boy who is diagnosed with this disorder, we revise the published literature of depersonalization in childhood


Assuntos
Humanos , Masculino , Criança , Despersonalização , Despersonalização/diagnóstico , Despersonalização/psicologia , Despersonalização/terapia
16.
Clin Microbiol Infect ; 20(11): 1205-10, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-24888250

RESUMO

Catheter-related bacteraemia (CRB) is a cause of death in hospitalized patients, and parenteral nutrition (PN) is a risk factor. We aim to describe the prognosis of PN-CRB and the impact of catheter extraction within 48 h from bacteraemia. All consecutive hospitalized adult patients with CRB (2007-2012) were prospectively enrolled. Factors associated with 30-day mortality were determined by logistic regression analysis. Among 847 episodes of CRB identified, 291 (34%) episodes were associated with short-term catheter use for PN. Cure was achieved in 236 (81%) episodes, 42 (14.5%) patients died within the first 30 days, 7 (2.5%) relapsed, and 6 (2%) had re-infection. On multivariate analysis, previous immunosuppressive therapy (OR 5.62; 95% CI 1.69-18.68; p 0.0048) and patient age (OR 1.05; 95% CI 1.02-1.07; p 0.0009) were predictors of 30-day mortality, whereas catheter removal within 48 h of bacteraemia onset (OR 0.26; 95% CI 0.12-0.58; p 0.0010) and adequate empirical antibiotic treatment (OR 0.36; 95% CI 0.17-0.77; p 0.0081) were protective factors. Incidence of PN-CRB decreased from 5.36 episodes/1000 days of PN in 2007 to 2.9 in 2012, yielding a 46.1% rate reduction (95% CI 15.7-65.5%), which may be attributable to implementation of a multifaceted prevention strategy. In conclusion, short-term PN-CRB accounted for one-third of all episodes of CRB in our setting, and 14.5% of patients died within 30 days following bacteraemia. Our findings suggest that prompt catheter removal and adequate empirical antibiotic treatment could be protective factors for 30-day mortality. Concomitantly with implementation of a multifaceted prevention strategy, PN-CRB incidence was reduced by half.


Assuntos
Bacteriemia/patologia , Infecções Relacionadas a Cateter/patologia , Infecção Hospitalar/patologia , Nutrição Parenteral/efeitos adversos , Adulto , Idoso , Antibacterianos/uso terapêutico , Bacteriemia/mortalidade , Infecções Relacionadas a Cateter/mortalidade , Estudos de Coortes , Infecção Hospitalar/mortalidade , Feminino , Hospitais , Humanos , Masculino , Pessoa de Meia-Idade , Prognóstico , Estudos Prospectivos , Análise de Sobrevida , Fatores de Tempo , Suspensão de Tratamento
17.
Nutr Hosp ; 29(6): 1360-5, 2014 Jun 01.
Artigo em Espanhol | MEDLINE | ID: mdl-24972475

RESUMO

OBJECTIVE: To report the data of the Home Parenteral Nutrition (HPN) registry of the NADYA-SENPE working group for the years 2011 and 2012. METHODOLOGY: We compiled the data from the on-line registry introduced by reviewers of NADYA group responsible for monitoring of NPD introduced by since January 1, 2011 to december 31, 2012. Included fields were: age, sex, diagnosis and reason for HPN, access path, complications, beginning and end dates, complementary oral or enteral nutrition, activity level, autonomy degree, product and fungible material supply, withdrawal reason and intestinal transplant indication. RESULTS: Year 2010: 184 patients from 29 hospitals , representing a rate of 3.98 patients/million inhabitants/ year 2011, with 186 episodes were recorded NPD . During 2012, 203 patients from 29 hospitals , representing a rate of 4.39 patients/million inhabitants/year 2012 , a total of 211 episodes were recorded NPD . CONCLUSIONS: We observe an increase in registered patients with respect to previous years.Neoplasia remains as the main pathology since 2003. Although NADYA is consolidated registry and has been indispensable source of information relevant to the understanding of the progress of Home Artificial Nutrition in our country, there is ample room for improvement. Especially that refers to the registration of pediatric patients and the registration of complications.


Objetivo: Comunicar los datos del registro de Nutrición Parenteral Domiciliaria (NPD) del grupo de trabajo NADYA-SENPE de los años 2011 y 2012. Material y métodos: Recopilación de los datos del registro "on-line" introducidos por los colaboradores del grupo NADYA responsables del seguimiento de la NPD desde el 1 de enero de 2011 al 31 de diciembre de 2012 dividido por años naturales. Resultados: Año 2010: Se registraron 184 pacientes, procedentes de 29 hospitales, lo que representa una tasa de 3,98 pacientes/millón habitantes/año 2011, con 186 episodios de NPD. Durante el año 2012 se registraron 203 pacientes, procedentes de 29 hospitales, lo que representa una tasa de 4,39 pacientes/millón habitantes/año 2012, con un total de 211 episodios de NPD. Conclusiones: Se observa un aumento progresivo de los pacientes registrados respecto a años anteriores. El principal grupo patológico sigue siendo oncológico ocupando el primer lugar desde 2003. Aunque el registro NADYA es un registro consolidado y ha sido y es fuente imprescindible de información relevante para el conocimiento de los avances de la Nutrición Artificial Domiciliaria en nuestro país, queda un amplio margen para la mejora. En especial lo que hace referencia al registro de pacientes pediátricos y al registro de las complicaciones.


Assuntos
Nutrição Parenteral no Domicílio/estatística & dados numéricos , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Criança , Pré-Escolar , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias/epidemiologia , Neoplasias/terapia , Soluções de Nutrição Parenteral , Nutrição Parenteral no Domicílio/efeitos adversos , Sistema de Registros , Espanha/epidemiologia , Adulto Jovem
18.
Panminerva Med ; 56(2 Suppl 3): 1-7, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24861886

RESUMO

AIM: The impetus of our study was to investigate the effects of a nutritional supplement Delphinol®, an extract of maqui berries (Aristotelia chilensis) standardised to ≥25% delphinidins and ≥35% total anthocyanins, on postprandial blood glucose and insulin levels and identify the physiologic mechanism involved. METHODS: Postprandial blood glucose and insulin were investigated in double-blind, placebo-controlled, cross-over fashion in ten volunteers with moderate glucose intolerance. Longer term effects on blood sugar levels were investigated in streptozotocin-diabetic rats over a four months period. Effects of maqui berry delphinidins on sodium-glucose symport were examined in rodent jejenum of the small intestine. RESULTS: Delphinol® intake prior to rice consumption statistical significantly lowered post prandial blood glucose and insulin as compared to placebo. We identified an inhibition of Na+-dependant glucose transport by delphinidin, the principal polyphenol to which Delphinol® is standardised. In a diabetic rat model the daily oral application of Delphinol® over a period of four months significantly lowered fasting blood glucose levels and reached values indistinguishable from healthy non-diabetic rats. CONCLUSION: Our results suggest a potential use of Delphinol® for naturally controlling post-prandial blood glucose owed to inhibition of sodium glucose co-transporter in small intestine.


Assuntos
Glicemia/efeitos dos fármacos , Elaeocarpaceae , Intolerância à Glucose/tratamento farmacológico , Hipoglicemiantes/uso terapêutico , Jejuno/efeitos dos fármacos , Extratos Vegetais/uso terapêutico , Proteínas de Transporte de Sódio-Glucose/antagonistas & inibidores , Animais , Antocianinas/análise , Antocianinas/uso terapêutico , Biomarcadores/sangue , Glicemia/metabolismo , Chile , Estudos Cross-Over , Diabetes Mellitus Experimental/sangue , Diabetes Mellitus Experimental/diagnóstico , Diabetes Mellitus Experimental/tratamento farmacológico , Método Duplo-Cego , Elaeocarpaceae/química , Feminino , Frutas , Intolerância à Glucose/sangue , Intolerância à Glucose/diagnóstico , Humanos , Hipoglicemiantes/efeitos adversos , Hipoglicemiantes/química , Insulina/sangue , Jejuno/metabolismo , Masculino , Camundongos Endogâmicos C57BL , Fitoterapia , Extratos Vegetais/efeitos adversos , Extratos Vegetais/química , Plantas Medicinais , Período Pós-Prandial , Ratos , Ratos Sprague-Dawley , Proteínas de Transporte de Sódio-Glucose/metabolismo , Fatores de Tempo , Resultado do Tratamento
19.
Rev. psiquiatr. infanto-juv ; 31(4): 36-42, 2014.
Artigo em Espanhol | IBECS | ID: ibc-185789

RESUMO

Presentamos el Caso Clínico de una niña diagnosticada de un Trastorno por Déficit de Atención e Hiperactividad que desarrolló una vasculopatía periférica (Síndrome de Raynaud) secundaria al tratamiento con metilfenidato. Se analizan las relaciones entre el tratamiento con metilfenidato y la aparición de fenómenos vasculares periféricos, su relevancia e implicaciones diagnósticas y terapéuticas


We report the case of a girl who is diagnosed of Attention Deficit Hyperactivity Disorder who developed a secondary peripheral vascular disease (Raynaud's Syndrome) after starting treatment with methylphenidate. The relationship between treatment with methylphenidate and the occurrence of peripheral vascular phenomena, its relevance and diagnostic and therapeutic implications are discussed


Assuntos
Humanos , Feminino , Criança , Transtorno do Deficit de Atenção com Hiperatividade/tratamento farmacológico , Metilfenidato/efeitos adversos , Estimulantes do Sistema Nervoso Central/efeitos adversos , Doença de Raynaud/induzido quimicamente , Doenças Vasculares Periféricas/induzido quimicamente , Estimulantes do Sistema Nervoso Central/uso terapêutico , Metilfenidato/uso terapêutico
20.
Acta Otorhinolaryngol Ital ; 33(6): 431-4, 2013 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-24376302

RESUMO

Osteomas are the most common fibro-osseous lesions in the paranasal sinus. They are benign tumours characterized by slow growth and are often asymptomatic. Treatment is indicated in sphenoid osteomas that threaten the optic canal or orbital apex and in symptomatic cases. The choice of surgical management depends on the location, size and experience of the surgeon. An open approach allows tumour removal with direct visual control and remains the best option in large tumours, but the continued progression in endoscopic approaches is responsible for new indications in closed techniques. Immediate reconstruction allows aesthetic and functional restoration of neighbouring structures, which should one of the goals in the treatment of this benign entity. We report a case of a giant ethmoid osteoma with orbital invasion treated by a combined open craniofacial approach with reconstruction of the anterior cranial base and orbital walls. The literature is reviewed and aetiopathogenic theories, diagnostic procedures and surgical approaches are discussed.


Assuntos
Seio Etmoidal , Neoplasias Orbitárias/patologia , Osteoma/patologia , Neoplasias dos Seios Paranasais/patologia , Neoplasias Cranianas/patologia , Feminino , Humanos , Pessoa de Meia-Idade , Invasividade Neoplásica , Neoplasias Orbitárias/cirurgia , Osteoma/cirurgia , Neoplasias dos Seios Paranasais/cirurgia , Neoplasias Cranianas/cirurgia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...